Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2012
06/20/2012CN101492417B Metallic copper chelidonamic acid complex and method for preparing the same
06/20/2012CN101151248B 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
06/20/2012CN101048380B Process for production of 2-hydroxy-4-substituted pyridines
06/19/2012US8203000 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
06/19/2012US8202999 Compounds for inflammation and immune-related uses
06/19/2012US8202997 Compositions and methods for treating or preventing hypoxic or ischemic injury
06/19/2012US8202885 Bridged six-membered ring compounds
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/19/2012US8202513 Aryl potassium channel blockers and uses thereof
06/19/2012CA2539469C Pyridylacetylenes for use as radiotracers and imaging agents
06/14/2012WO2012078593A2 Lysophosphatidic acid receptor antagonists and uses thereof
06/14/2012WO2012077765A1 Polynuclear platinum complex catalyst and method of artificial photosynthesis using same
06/14/2012WO2012076560A1 Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
06/14/2012WO2012076413A1 Compound for the treatment of tumours and tumour metastases
06/14/2012WO2012076367A1 3-cyanopyridinium tricyanomethanides
06/14/2012WO2012075917A1 Compounds
06/14/2012US20120149910 Pesticidal Carboxamides
06/14/2012US20120149738 Novel inhibitors of proliferation and activation of signal transducer and activators of transcription (stats)
06/14/2012US20120149737 Therapeutic Aryl-Amido-Aryl Compounds and Their Use
06/14/2012US20120149736 Enzyme inhibitors
06/14/2012US20120149735 1,4-Dihydropyridine Derivatives and Their Uses
06/14/2012US20120149732 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149693 Therapeutic compounds
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120149653 Multifunctional linkers and methods for the use thereof
06/14/2012US20120148955 Resist composition, method of forming resist pattern, and new compound
06/14/2012US20120145238 Dye sensitised solar cell
06/14/2012CA2820817A1 Lysophosphatidic acid receptor antagonists and uses thereof
06/14/2012CA2820430A1 Process for the homogeneously catalysed, highly selective direct amination of primary alcohols by means of ammonia to form primary amines at a high volume ratio of liquid phase to gas phase and/or high pressures
06/14/2012CA2820114A1 Compound for the treatment of tumours and tumour metastases
06/14/2012CA2820044A1 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
06/13/2012EP2463268A1 Aminomethyl-substituted aromatic acids as intermediates for the preparation of chymase inhibiting 1,4-diazepan-2,5-dione compounds
06/13/2012EP2463266A1 Process for production of bis-quaternary ammonium salt, and novel intermediate
06/13/2012EP2462116A2 Process for the manufacture of pharmaceutically active compounds
06/13/2012EP1979311B1 Phenoxy acetic acids as ppar delta activators
06/13/2012EP1797038B1 Thermodynamically stable form of bay 43-9006 tosylate
06/13/2012EP1781635B1 Potassium channel inhibitors
06/13/2012EP1618087B1 Antibacterial agents
06/13/2012CN102498101A Aniline compounds
06/13/2012CN102498100A Heterocyclic antiviral compounds
06/13/2012CN102491944A Method for preparing brominated 1-benzyl-3-carboxypyridine and preparation method thereof
06/13/2012CN102491943A Improved 2-chlorine-5-chloromethyl pyridine synthesis process
06/13/2012CN102491942A Production method of high-purity PPS-OH
06/13/2012CN102491862A Method for preparing biaryl compound in pure water
06/13/2012CN101955470B Potentiators of glutamate receptors
06/13/2012CN101856622B Pyridine base-synthesized cocrystallized zeolite catalyst and preparation method thereof
06/13/2012CN101410375B Method for producing aromatic compound
06/13/2012CN101330831B Bactericidal composition comprising carboxylic acid amide derivative
06/13/2012CN101094827B Benzene compound having two or more substituents
06/12/2012US8198483 Phenethanolamine derivatives for treatment of respiratory diseases
06/12/2012US8198457 3-arylamino pyridine derivatives
06/12/2012US8198454 Amide derivatives and medicinal use thereof
06/12/2012US8198304 Guanidine-containing compounds useful as muscarinic receptor antagonists
06/12/2012CA2662242C Benzo-fused compounds for use in treating metabolic disorders
06/07/2012WO2012074857A2 Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
06/07/2012WO2012074050A1 Polymer film, phase difference film, polarization plate, liquid crystal display, and compound
06/07/2012WO2012074012A1 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
06/07/2012WO2012073699A1 Rare earth metal complex
06/07/2012WO2012027274A3 Compositions and methods for imaging
06/07/2012WO2011023986A8 Kinase inhibitors
06/07/2012US20120142934 Method for synthesis of secondary alcohols
06/07/2012US20120142933 Process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
06/07/2012US20120142743 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
06/07/2012US20120142742 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
06/07/2012US20120142707 Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142688 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications
06/07/2012US20120142668 Cathepsin c inhibitors
06/07/2012CA2818513A1 Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
06/06/2012EP2459537A2 Method and substances for preparation of n-substituted pyridinium compounds
06/06/2012EP2459536A2 Method and substances for preparation of n-substituted pyridinium compounds
06/06/2012EP2459535A1 Pyridine and pyrazine derivatives as protein kinase modulators
06/06/2012EP2459534A1 Process for the selective preparation of 3-methylpyridine (3-picoline) from acrolein and one or more ammonium salts dissolved in water
06/06/2012EP2459524A2 Novel compounds as modulators of glucocorticoid receptors
06/06/2012CN102485714A Method for synthesis of sorafenib through carbonylation
06/06/2012CN102485713A Novel method for synthesizing Atazanavir
06/06/2012CN101848893B 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
06/06/2012CN101723977B 1-(2-phenyl indenyl) dicyclohexylphosphonium tetrafluoroborate as well as preparation method and application thereof
06/06/2012CN101544599B Crystal of 1,2-dihydropyridine compound
06/06/2012CN101362716B Preparation method of 3-trifluoro ethoxy pyridine-2-sulfonic acid amide
06/06/2012CN101098855B 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
06/05/2012US8193364 Insecticidal N-substituted (6-haloalkylpyridin-3-yl)-alkyl sulfoximines
06/05/2012CA2585623C Ortho-substituted benzene derivatives
05/2012
05/31/2012WO2012071425A1 Solid state forms of sorafenib besylate, and processes for preparations thereof
05/31/2012WO2012070535A1 Electron transport material, and organic electroluminescent element using same
05/31/2012WO2012070015A1 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
05/31/2012WO2012069852A1 Pharmaceutical compounds as inhibitors of sphingosine kinase
05/31/2012WO2012069608A1 Technetium-99m complex as a tool for the in vivo diagnosis of cancerous tumours
05/31/2012WO2012069428A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
05/31/2012WO2012069402A1 Substituted cyclopentyl - azines as casr- active compounds
05/31/2012US20120136158 Pyridinyl Compounds Useful As Intermediates
05/31/2012US20120136157 Aryl ureas as kinase inhibitors
05/31/2012US20120136002 Protease inhibitors
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135968 Tetracycline Compounds
05/31/2012US20120135249 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties
05/31/2012US20120132899 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
05/30/2012EP2457896A1 Tripeptides as caspase modulators
05/30/2012EP2457895A1 Tetrapeptide analogs
05/30/2012EP2457893A1 Intermediates for macrocyclic modulators of the ghrelin receptor
05/30/2012EP2456758A1 A process for preparing trisubstituted phenyl derivatives comprising a (1h-1,2,4-triazol-1-yl)alkyl group
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 633